Financial Advocates Investment Management’s Virtus Biotech ETF BBP Stock Holding History

Financial Advocates Investment Management’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,455	Closed	-$368K	–	695
2022 Q1	$368K	Sell	8,455 -120	-1%	-$5.16K	0.02%	520
2021 Q4	$419K	Sell	8,575 -1,200	-12%	-$59.6K	0.03%	533
2021 Q3	$498K	Hold	9,775	–	–	0.03%	476
2021 Q2	$522K	Sell	9,775 -620	-6%	-$32.7K	0.03%	472
2021 Q1	$544K	Sell	10,395 -1,000	-9%	-$55.8K	0.04%	462
2020 Q4	$606K	Sell	11,395 -250	-2%	-$12.8K	0.04%	406
2020 Q3	$555K	Hold	11,645	–	–	0.05%	356
2020 Q2	$552K	Hold	11,645	–	–	0.05%	341
2020 Q1	$436K	Hold	11,645	–	–	0.06%	297
2019 Q4	$507K	Sell	11,645 -1,200	-9%	-$48.2K	0.05%	309
2019 Q3	$461K	Hold	12,845	–	–	0.05%	304
2019 Q2	$527K	Sell	12,845 -1,000	-7%	-$41.2K	0.06%	284
2019 Q1	$620K	Hold	13,845	–	–	0.08%	236
2018 Q4	$483K	Buy	13,845 +750	+6%	+$28.5K	0.07%	251
2018 Q3	$595K	Sell	13,095 -260	-2%	-$11.6K	0.07%	259
2018 Q2	$587K	Sell	13,355 -550	-4%	-$23.3K	0.07%	247
2018 Q1	$574K	Hold	13,905	–	–	0.07%	236
2017 Q4	$564K	Buy	+13,905	New	+$555K	0.08%	239

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CCM

Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Financial Advocates Investment Management's BBP Position: Q2 2022 in Review

Financial Advocates Investment Management sold out of Virtus Biotech ETF (BBP) in Q2 2022, closing a stake of 8,455 shares — an estimated $368K sold.

Financial Advocates Investment Management first reported a position in BBP in Q4 2017 and held it in 18 quarters. The position peaked at $620K in Q1 2019. 11 funds tracked by Wall St. Rank hold BBP as of Q2 2022.

Financial Advocates Investment Management reported no remaining Virtus Biotech ETF position as of Q2 2022 after selling out during the quarter.
Financial Advocates Investment Management sold 8,455 Virtus Biotech ETF shares in Q2 2022, an estimated $368K.
Financial Advocates Investment Management first reported a position in Virtus Biotech ETF in Q4 2017 and held it in 18 quarters.
Financial Advocates Investment Management's Virtus Biotech ETF position peaked at $620K in Q1 2019.
11 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2022.

Based on Financial Advocates Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.